It's not easy being green: the viridans group streptococci, with a focus on pediatric clinical manifestations.
The viridans group streptococci (VGS) are a heterogeneous group of organisms that can be human commensals, colonizing the gastrointestinal and genitourinary tracts in addition to the oral mucosa. VGS are generally considered to be of low pathogenic potential in immunocompetent individuals. However, in certain patient populations, VGS can cause invasive disease, such as endocarditis, intra-abdominal infection, and shock. Within the VGS, the rates and patterns of antimicrobial resistance vary greatly depending upon the species identification and the patient population. In general, Streptococcus mitis group organisms are resistant to more antimicrobial agents than the other VGS species. This review addresses current VGS taxonomy, in addition to the current methodologies being used in clinical microbiology laboratories for identification of VGS. Automated systems struggle overall with species level identification and susceptibility testing for VGS. Matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) identification is emerging as a potential alternative for organism identification. A review of recent pediatric-specific data regarding the clinical manifestations of VGS revealed that the Streptococcus anginosus group (SAG) organisms may be important pathogens in pediatric patients and that the VGS may contribute to disease in patients with cystic fibrosis. It also appears that rates of antimicrobial resistance in VGS in pediatric patients are surpassing those of the adult population.
Doern
Christopher D
CD
Department of Pathology, University of Texas Southwestern, Dallas, Texas 75235, USA. christopher.doern@utsouthwestern.edu
Burnham
Carey-Ann D
CA
D015373:Bacterial Typing Techniques / Q000379:methods; D004352:Drug Resistance, Microbial; D004696:Endocarditis / Q000382:microbiology; D006801:Humans; D010538:Peritonitis / Q000382:microbiology; D012772:Shock, Septic / Q000382:microbiology; D013290:Streptococcal Infections / Q000175:diagnosis* / Q000382:microbiology / Q000473:pathology*; D013291:Streptococcus / Q000145:classification / Q000187:drug effects / Q000302:isolation & purification* / Q000472:pathogenicity*
Pediatr Infect Dis J. 1997 Dec;16(12):1140-4
9427459
Lancet. 2007 Feb 10;369(9560):482-90
17292768
Calif Med. 1949 Dec;71(6):403-8
15408107
J Clin Microbiol. 1998 Jan;36(1):41-7
9431917
Mol Microbiol. 2003 Dec;50(5):1477-91
14651632
J Clin Microbiol. 1992 Jan;30(1):243-4
1734062
Cancer. 1999 Jul 1;86(1):126-34
10391572
J Clin Microbiol. 2010 May;48(5):1584-91
20237093
Diagn Microbiol Infect Dis. 2008 Jun;61(2):235-9
18314293
Circulation. 1975 Apr;51(4):581-8
1116249
J Clin Microbiol. 1996 Aug;34(8):2020-2
8818904
Int J Syst Evol Microbiol. 2002 Jul;52(Pt 4):1247-1255
12148636
Clin Infect Dis. 2001 May 15;32(10):1511-5
11317256
J Clin Microbiol. 2007 Aug;45(8):2392-7
17553974
Diagn Microbiol Infect Dis. 2005 Nov;53(3):169-73
16243478
Int J Syst Bacteriol. 1999 Oct;49 Pt 4:1443-9
10555325
Clin Infect Dis. 1998 Dec;27(6):1451-6
9868659
J Clin Microbiol. 2008 Jul;46(7):2184-8
18495854
Pediatr Infect Dis J. 2005 Jun;24(6):563-6
15933573
Circulation. 2009 Feb 17;119(6):865-70
19188508
Infection. 2001 Oct;29(5):251-6
11688901
Proc Natl Acad Sci U S A. 2008 Sep 30;105(39):15070-5
18812504
J Clin Microbiol. 1990 Jul;28(7):1497-501
2380375
J Infect. 1997 Sep;35(2):135-41
9354347
Clin Microbiol Rev. 2002 Oct;15(4):613-30
12364372
Pediatr Infect Dis J. 1995 Jan;14(1):80-2
7716003
Clin Infect Dis. 2002 Jun 1;34(11):1469-74
12015693
J Clin Microbiol. 2008 Sep;46(9):2966-72
18614655
J Clin Microbiol. 2003 Jul;41(7):3433-5
12843113
Eur J Clin Microbiol Infect Dis. 2002 Dec;21(12):869-74
12525922
Pediatrics. 2004 Oct;114(4):e409-17
15466065
J Clin Oncol. 2000 May;18(9):1845-55
10784625
J Antimicrob Chemother. 2009 Sep;64(3):501-6
19584106
J Clin Microbiol. 2004 Oct;42(10):4686-96
15472328
Ann Hematol. 1992 Jun;64(6):260-5
1637878
Pediatr Pulmonol. 2008 May;43(5):490-7
18383109
Infect Immun. 1995 Mar;63(3):785-93
7868248
J Pediatr Hematol Oncol. 2006 Sep;28(9):627-9
17006272
BMC Microbiol. 2007 May 23;7:46
17521437
Clin Microbiol Rev. 1989 Jul;2(3):315-28
2670193
J Clin Microbiol. 1995 May;33(5):1215-22
7615731
Pediatrics. 2002 May;109(5):931-43
11986458
J Clin Microbiol. 2007 Sep;45(9):2863-71
17652483
Clin Infect Dis. 1995 Feb;20(2):476-7
7742466
J Clin Microbiol. 2003 Jul;41(7):3051-5
12843042
J Pediatr. 2002 Jan;140(1):20-6
11815759
Antimicrob Agents Chemother. 2005 Feb;49(2):820-3
15673778
Clin Infect Dis. 1997 Apr;24(4):669-75
9145742
Pediatr Infect Dis J. 2002 Aug;21(8):715-23
12192158
J Pediatr. 1999 Nov;135(5):618-23
10547251
J Clin Microbiol. 2010 May;48(5):1542-8
20237092
J Clin Oncol. 2004 Apr 1;22(7):1222-7
15051769
Scand J Infect Dis. 2005;37(9):637-41
16126562
J Clin Microbiol. 2006 Sep;44(9):3263-7
16954258
J Clin Microbiol. 2005 Dec;43(12):5983-91
16333086